Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > New study shows cannabis terpenes may relieve chemotherapy
View:
Post by blackspade799 on May 31, 2024 5:55pm

New study shows cannabis terpenes may relieve chemotherapy

A University of Arizona Health Sciences study published in the journal Pain found that Cannabis sativa terpenes were as effective as morphine at reducing chronic neuropathic pain and a combination of the two analgesics further enhanced pain relief without negative side effects.

Some prior studies have shown that the Cannabis sativa plant and its two primary cannabinoids, tetrahydrocannabinol, or THC, and cannabidiol, or CBD, can be effective in managing chronic pain; however, the effects are generally moderate and can come with unwanted psychoactive side effects. Terpenes, the compounds that give plants their aroma and taste, offer an alternative path to pain relief without adverse side effects.

"A question that we've been very interested in is could terpenes be used to manage chronic pain?" said lead researcher John Streicher, Ph.D., a member of the Comprehensive Center for Pain & Addiction and a professor of pharmacology at the College of Medicine, Tucson. "What we found is that terpenes are really good at relieving a specific type of chronic pain with side effects that are low and manageable."

https://medicalxpress.com/news/2024-05-cannabis-terpenes-relieve-chemotherapy-neuropathic.html

Comment by Saxman on Jun 01, 2024 8:41am
It appears with clinic trials on going and an Ip in a few weeks the UK group is well ahead of any studies being carried out in the US. The study done in Arizona only confirms Dr Mikael Soderdren's findings.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities